![Logo of OpenAlex.org Project OpenAlex Citations Logo](https://www.oahelper.org/wp-content/plugins/oahelper-citations/img/logo-openalex.jpg)
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
PLGA Particles in Immunotherapy
Dennis J. Horvath, Michael Basler
Pharmaceutics (2023) Vol. 15, Iss. 2, pp. 615-615
Open Access | Times Cited: 25
Dennis J. Horvath, Michael Basler
Pharmaceutics (2023) Vol. 15, Iss. 2, pp. 615-615
Open Access | Times Cited: 25
Showing 25 citing articles:
Versatile PLGA‐Based Drug Delivery Systems for Tumor Immunotherapy
Yishu Wang, Xiaoming Hu, Jinghui Wang, et al.
Small Methods (2025)
Closed Access
Yishu Wang, Xiaoming Hu, Jinghui Wang, et al.
Small Methods (2025)
Closed Access
Use of Poly Lactic-co-glycolic Acid Nano and Micro Particles in the Delivery of Drugs Modulating Different Phases of Inflammation
Chiara Puricelli, Casimiro Luca Gigliotti, Ian Stoppa, et al.
Pharmaceutics (2023) Vol. 15, Iss. 6, pp. 1772-1772
Open Access | Times Cited: 18
Chiara Puricelli, Casimiro Luca Gigliotti, Ian Stoppa, et al.
Pharmaceutics (2023) Vol. 15, Iss. 6, pp. 1772-1772
Open Access | Times Cited: 18
Biomaterials for inflammatory bowel disease: treatment, diagnosis and organoids
Jia Wang, Yuying Shi, Bei Mao, et al.
Applied Materials Today (2024) Vol. 36, pp. 102078-102078
Closed Access | Times Cited: 5
Jia Wang, Yuying Shi, Bei Mao, et al.
Applied Materials Today (2024) Vol. 36, pp. 102078-102078
Closed Access | Times Cited: 5
The drug release of PLGA-based nanoparticles and their application in treatment of gastrointestinal cancers
Rui Sun, Yanfei Chen, Yan-Jiang Pei, et al.
Heliyon (2024) Vol. 10, Iss. 18, pp. e38165-e38165
Open Access | Times Cited: 4
Rui Sun, Yanfei Chen, Yan-Jiang Pei, et al.
Heliyon (2024) Vol. 10, Iss. 18, pp. e38165-e38165
Open Access | Times Cited: 4
Next-Generation Vaccine Development with Nanomaterials: Recent Advances, Possibilities, and Challenges
Shamitha Shetty, Pablo Cordero Alvarado, Deleah Pettie, et al.
Annual Review of Biomedical Engineering (2024) Vol. 26, Iss. 1, pp. 273-306
Closed Access | Times Cited: 4
Shamitha Shetty, Pablo Cordero Alvarado, Deleah Pettie, et al.
Annual Review of Biomedical Engineering (2024) Vol. 26, Iss. 1, pp. 273-306
Closed Access | Times Cited: 4
Tailoring biomaterials for vaccine delivery
Yanling Zhuo, Huanxuan Zeng, Chunyu Su, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 4
Yanling Zhuo, Huanxuan Zeng, Chunyu Su, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 4
Advances in dendritic cell targeting nano-delivery systems for induction of immune tolerance
Guojiao Lin, Jialiang Wang, Yong‐Guang Yang, et al.
Frontiers in Bioengineering and Biotechnology (2023) Vol. 11
Open Access | Times Cited: 9
Guojiao Lin, Jialiang Wang, Yong‐Guang Yang, et al.
Frontiers in Bioengineering and Biotechnology (2023) Vol. 11
Open Access | Times Cited: 9
A Review of the Potential of Poly-(lactide-co-glycolide) Nanoparticles as a Delivery System for an Active Antimycobacterial Compound, 7-Methyljuglone
Bianca Diedericks, Anna-Mari Kok, Vusani Mandiwana, et al.
Pharmaceutics (2024) Vol. 16, Iss. 2, pp. 216-216
Open Access | Times Cited: 2
Bianca Diedericks, Anna-Mari Kok, Vusani Mandiwana, et al.
Pharmaceutics (2024) Vol. 16, Iss. 2, pp. 216-216
Open Access | Times Cited: 2
PLGA-PEI nanoparticle covered with poly(I:C) for personalised cancer immunotherapy
Lorena Gonzalez-Melero, Edorta Santos‐Vizcaíno, Rubén Varela‐Calviño, et al.
Drug Delivery and Translational Research (2024) Vol. 14, Iss. 10, pp. 2788-2803
Open Access | Times Cited: 2
Lorena Gonzalez-Melero, Edorta Santos‐Vizcaíno, Rubén Varela‐Calviño, et al.
Drug Delivery and Translational Research (2024) Vol. 14, Iss. 10, pp. 2788-2803
Open Access | Times Cited: 2
Interleukin-10-alveolar macrophage cell membrane-coated nanoparticles alleviate airway inflammation and regulate Th17/regulatory T cell balance in a mouse model
Junda Li, Jia Yin
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 5
Junda Li, Jia Yin
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 5
Immune Potentiation of PLGA Controlled-Release Vaccines for Improved Immunological Outcomes
Britteny Cassaidy, Brittany A. Moser, Ani Solanki, et al.
ACS Omega (2024) Vol. 9, Iss. 10, pp. 11608-11614
Open Access | Times Cited: 1
Britteny Cassaidy, Brittany A. Moser, Ani Solanki, et al.
ACS Omega (2024) Vol. 9, Iss. 10, pp. 11608-11614
Open Access | Times Cited: 1
Current Progress in the Science of Novel Adjuvant Nano-Vaccine-Induced Protective Immune Responses
Mansab Ali Saleemi, Yan Zhang, Guoquan Zhang
Pathogens (2024) Vol. 13, Iss. 6, pp. 441-441
Open Access | Times Cited: 1
Mansab Ali Saleemi, Yan Zhang, Guoquan Zhang
Pathogens (2024) Vol. 13, Iss. 6, pp. 441-441
Open Access | Times Cited: 1
Nanoparticle-Mediated Immunotherapy in Triple-Negative Breast Cancer
Ruoyi Wang, Xu Huang, Xiaoxi Chen, et al.
ACS Biomaterials Science & Engineering (2024) Vol. 10, Iss. 6, pp. 3568-3598
Open Access | Times Cited: 1
Ruoyi Wang, Xu Huang, Xiaoxi Chen, et al.
ACS Biomaterials Science & Engineering (2024) Vol. 10, Iss. 6, pp. 3568-3598
Open Access | Times Cited: 1
Designing biomaterials for the treatment of autoimmune diseases
Beikang Tang, Xiaoyan Xie, Juan Lu, et al.
Applied Materials Today (2024) Vol. 39, pp. 102278-102278
Closed Access | Times Cited: 1
Beikang Tang, Xiaoyan Xie, Juan Lu, et al.
Applied Materials Today (2024) Vol. 39, pp. 102278-102278
Closed Access | Times Cited: 1
Enhancing Diabetic Wound Healing Through Anti-bacterial and Promoting Angiogenesis Using Dual-Functional Slow-Release Microspheres-loaded dermal scaffolds
Chaotao Hu, Biao Hou, Fen Yang, et al.
Colloids and Surfaces B Biointerfaces (2024) Vol. 242, pp. 114095-114095
Closed Access | Times Cited: 1
Chaotao Hu, Biao Hou, Fen Yang, et al.
Colloids and Surfaces B Biointerfaces (2024) Vol. 242, pp. 114095-114095
Closed Access | Times Cited: 1
Enhancing Vaccine Efficacy and Stability: A Review of the Utilization of Nanoparticles in mRNA Vaccines
Nargish Parvin, Sang Woo Joo, Tapas Kumar Mandal
Biomolecules (2024) Vol. 14, Iss. 8, pp. 1036-1036
Open Access | Times Cited: 1
Nargish Parvin, Sang Woo Joo, Tapas Kumar Mandal
Biomolecules (2024) Vol. 14, Iss. 8, pp. 1036-1036
Open Access | Times Cited: 1
Development and evaluation of cell membrane-based biomimetic nanoparticles loaded by Clostridium perfringens epsilon toxin: a novel vaccine delivery platform for Clostridial -associated diseases
Mokarameh Pudineh Moarref, Mojtaba Alimolaei, Tara Emami, et al.
Nanotoxicology (2023) Vol. 17, Iss. 5, pp. 420-431
Closed Access | Times Cited: 3
Mokarameh Pudineh Moarref, Mojtaba Alimolaei, Tara Emami, et al.
Nanotoxicology (2023) Vol. 17, Iss. 5, pp. 420-431
Closed Access | Times Cited: 3
Artificial Dendritic Cells: A New Era of Promising Antitumor Immunotherapy
Daniela Mateus, Ana Isabel Sebastião, Manuela F. Frasco, et al.
Small (2023) Vol. 19, Iss. 46
Open Access | Times Cited: 2
Daniela Mateus, Ana Isabel Sebastião, Manuela F. Frasco, et al.
Small (2023) Vol. 19, Iss. 46
Open Access | Times Cited: 2
Polymeric Particle BAM15 Targeting Macrophages Attenuates the Severity of LPS-Induced Sepsis: A Proof of Concept for Specific Immune Cell-Targeted Therapy
Kanyarat Udompornpitak, Thansita Bhunyakarnjanarat, Wilasinee Saisorn, et al.
Pharmaceutics (2023) Vol. 15, Iss. 12, pp. 2695-2695
Open Access | Times Cited: 2
Kanyarat Udompornpitak, Thansita Bhunyakarnjanarat, Wilasinee Saisorn, et al.
Pharmaceutics (2023) Vol. 15, Iss. 12, pp. 2695-2695
Open Access | Times Cited: 2
Bioinformatic, Biochemical, and Immunological Mining of MHC Class I Restricted T Cell Epitopes for a Marburg Nucleoprotein Microparticle Vaccine
Paul E. Harris, Scott Burkholz, C.v. Herst, et al.
Vaccines (2024) Vol. 12, Iss. 3, pp. 322-322
Open Access
Paul E. Harris, Scott Burkholz, C.v. Herst, et al.
Vaccines (2024) Vol. 12, Iss. 3, pp. 322-322
Open Access
Nanospheres as the delivery vehicle: novel application of Toxoplasma gondii ribosomal protein S2 in PLGA and chitosan nanospheres against acute toxoplasmosis
WeiYu Qi, YouLi Yu, Chenchen Yang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
WeiYu Qi, YouLi Yu, Chenchen Yang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
In memory of Prof. Dr. Marcus Groettrup (1964–2022)
Michael Basler, Christopher Schliehe
European Journal of Immunology (2024) Vol. 54, Iss. 9
Closed Access
Michael Basler, Christopher Schliehe
European Journal of Immunology (2024) Vol. 54, Iss. 9
Closed Access
In vitro anti-trypanosomal activity of 3-(aryl)-6-piperazin1,2,4-triazolo[3,4-a]phthalazines-loaded ultrathin polymeric particles: effect of polymer type and particle size
Karina González, Ender Medina, Elena Aguilera, et al.
RSC Pharmaceutics (2024) Vol. 1, Iss. 1, pp. 108-120
Open Access
Karina González, Ender Medina, Elena Aguilera, et al.
RSC Pharmaceutics (2024) Vol. 1, Iss. 1, pp. 108-120
Open Access
PEI‐Engineered Lipid@PLGA Hybrid Nanoparticles for Multimodal Delivery of Antigens and Immune Adjuvants to the Respiratory Mucosa
Susy Brusco, Gemma Conte, Annunziata Corteggio, et al.
Advanced Healthcare Materials (2024)
Open Access
Susy Brusco, Gemma Conte, Annunziata Corteggio, et al.
Advanced Healthcare Materials (2024)
Open Access
Advancements in nanoparticles-based therapies for biomedical applications
VijayaDurga V. V. Lekkala, Madhava C. Reddy, Vajra C. Reddy, et al.
Nano-Structures & Nano-Objects (2024) Vol. 40, pp. 101365-101365
Closed Access
VijayaDurga V. V. Lekkala, Madhava C. Reddy, Vajra C. Reddy, et al.
Nano-Structures & Nano-Objects (2024) Vol. 40, pp. 101365-101365
Closed Access